Disease Markers / 2016 / Article / Fig 1

Research Article

Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study

Figure 1

ROC curves for plasma BDNF to diagnose MNCD-AD (a) and ScVMNCD (b). AUCs (95% confidence intervals) are 0.866 (0.733–0.999) for MNCD-AD () and 0.679 (0.506–0.852) for ScVMNCD (). ROC receiver-operating characteristic. AUC area under the curve. MNCD-AD mild neurocognitive disorder due to Alzheimer’s disease. ScVMNCD subcortical mild neurocognitive disorder.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.